For more information, visit Formycon AG at Fraunhoferstr. 15, 82152 Martinsried/Planegg, Germany. Contact them via phone at +49 (0) 89 - 86 46 67 100 or email at [email protected].
Formycon AG
The Biosimilar Experts
Founded 2012
Planegg, Germany
168 employees
Post-IPO Equity
Total: $83.13M
Biopharma
Planegg, Germany
168 employees
Post-IPO Equity
Total: $83.13M
Biopharma
General Information
Company Name
Formycon AG
Founded Year
2012
Location
Planegg, Germany
Planegg, Germany
Employees
168
Industries
Biopharma
Funding Stage
Post-IPO Equity
BounceWatch is an independent company data service, not affiliated with Formycon AG. To contact Formycon AG, visit formycon.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Formycon AG compare?
A PDF of Formycon AG and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Formycon AG soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Germany Market
Biopharma
About Formycon AG
Business keywords: Biosimilars, Biopharmaceuticals, Ophthalmology, Immunology, Chronic Diseases, Drug Development, Clinical Trials, Regulatory Approval, Biotech Drugs, COVID-19 Drug, GMP Quality Control, Formulation Development, Analytical Services, CMC Regulatory Affairs, Project Management
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | €82.84M | 1 |
Richter Group
|
29 Jan 2024 |
| Grant | €290.00K | 1 |
Bavarian Research Foundation
|
13 Oct 2020 |
Formycon AG Alternatives & Competitors
View All Alternatives
Formycon AG vs
Innovent Biologics
China
To develop and commercialize high-quality biopharmaceuticals that are affordable to ordinary people
Post-IPO Equity
846 employees
Biopharma, Biotechnology
Formycon AG vs
JOINN Biologics US Inc.
United States
Your premier CDMO for biologics drug development and manufacturing, from early development, to IND,...
Series B
73 employees
Biopharma, Biotechnology
Formycon AG vs
Perceive Biotherapeutics, Inc.
United States
A start-up developing novel ophthalmic therapeutics to treat major unmet needs for patients. PLEASE...
Series B
20 employees
Biopharma, Biotechnology
FAQ About Formycon AG
The Biosimilar Experts
Formycon AG was founded in 2012.
Formycon AG is headquartered in Planegg, Germany.
Formycon AG operates in Biopharma. Its work centres on Biosimilars, Biopharmaceuticals, Ophthalmology and Immunology.
Formycon AG has approximately 168 employees.
Formycon AG has completed 2 funding rounds, raising a total of $83.13M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Formycon AG include Innovent Biologics, JOINN Biologics US Inc., Perceive Biotherapeutics, Inc., HiRO - Harvest Integrated Research Organization, CMAB Biopharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Formycon AG and Innovent Biologics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Formycon AG, https://bouncewatch.com/company/formycon-ag, updated 26 September 2026. When citing, please name BounceWatch and link this page.
